ghk-cu clinical trial dose GHK Peptide as a Natural Modulator of Multiple Cellular Pathways in Skin Regeneration Peptides & GHK-Copper in Skin

W., Bowman, B

Angiogenesis 21(1):114 Sharma S, Brown CE (2021) Microvascular basis of cognitive impairment in type 1 diabetes

It's the only method that meets professional laboratory standards

Four molecule families have peer-reviewed clinical evidence supporting their use in microinfusion-style delivery: copper tripeptide GHK-Cu (collagen synthesis, gene-expression modulation), recombinant epidermal growth factor or sh-Oligopeptide-1 (keratinocyte proliferation, dermal restructuring), polydeoxyribonucleotide PDRN (adenosine A2A receptor activation, fibroblast stimulation, anti-melanogenesis), and a multi-molecular-weight hyaluronic acid system (50 kDa to 2000 kDa fractions, each with different penetration depth and biological role)

Heredity 105 , 122134 (2010)